Severe pulmonary infections due to biological therapy of rheumatic diseases Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
Intrabronchial lymphotropic immune and antibiotic therapy in complex treatment of the chronic obstructive disease of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 524s Year: 2004
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Intrabronchial lymphotropic immune and antibiotic therapy in complex treatment of acute lung abscess Source: Eur Respir J 2001; 18: Suppl. 33, 303s Year: 2001
Bronchial resistance of community acquired pneumonia patients Source: Eur Respir J 2006; 28: Suppl. 50, 655s Year: 2006
Intrabronchial lymphotropic immune and antibiotic therapy in complex treatment of pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002
Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis Source: Eur Respir J 2006; 27: 1307-1310 Year: 2006
Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Cytomegalovirus antigenemina in idiopathic interstitial pneumonias and collagen vascular disease-related lung diseases treated with immunosuppressive drugs Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Localized pulmonary infection associated with Mycobacterium tilburgii in a HIV-infected patient Source: Eur Respir J 2005; 26: Suppl. 49, 191s Year: 2005
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004
Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013
Candidosis due to treatment pulmonary diseases Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010
Diagnosis and treatment‘s management of the MDR tuberculosis in a chronic pulmonary diseases department Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005
Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Source: Annual Congress 2006 - MP6 – Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Year: 2006
Pulmonary fungal infection in paediatric cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001